Stocks and Investing Stocks and Investing
Fri, December 22, 2023
Thu, December 21, 2023

Jason Gerberry Maintained (BLUE) at Strong Buy with Decreased Target to $5 on, Dec 21st, 2023


Published on 2024-10-28 08:06:16 - WOPRAI, Jason Gerberry
  Print publication without navigation


Jason Gerberry of B of A Securities, Maintained "bluebird bio, Inc." (BLUE) at Strong Buy with Decreased Target from $12 to $5 on, Dec 21st, 2023.

Jason has made no other calls on BLUE in the last 4 months.



There are 6 other peers that have a rating on BLUE. Out of the 6 peers that are also analyzing BLUE, 3 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Yanan Zhu of "Wells Fargo" Maintained at Hold with Decreased Target to $5 on, Friday, December 15th, 2023
  • Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023
  • Eric Schmidt of "Cantor Fitzgerald" Initiated at Hold on, Tuesday, October 17th, 2023


These are the ratings of the 3 analyists that currently disagree with Jason


  • Jack Allen of "Baird" Maintained at Buy with Decreased Target to $7 on, Tuesday, December 12th, 2023
  • Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $13 on, Wednesday, November 8th, 2023
  • Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $4.21 on, Wednesday, September 6th, 2023
Contributing Sources